SMTL ID : 6uip.3 (2 other biounits)

DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.70 Å

Oligo State

monomer

Ligands

1 x Q8J: 4-ethyl-N-{4-[1-(oxan-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl}piperazine-1-carboxamide(Non-covalent)

Q8J.1: 17 residues within 4Å: Chain A: I.41, F.46, V.49, A.62, K.64, E.79, F.114, E.115, M.116, L.117, S.118, Y.119, E.167, N.168, L.170, V.182, D.183 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.49, A:Y.119, A:L.170, A:V.182 Hydrogen bonds: A:L.117, A:L.117 pi-Stacking: A:F.114

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, Y.A. et al., Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. J.Med.Chem. (2020)

Release Date

2020-03-04

Peptides

Dual specificity tyrosine-phosphorylation-regulated kinase 1A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Dual specificity tyrosine-phosphorylation-regulated kinase 1A

Related Entries With Identical Sequence